Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: A reappraisal of the role of S-cerevisiae in this setting

被引：8
|
作者：
Sendid, B. [1 ,2 ]
Jawhara, S. [1 ]
Sarter, H. [1 ]
Maboudou, P. [3 ]
Thierny, C. [3 ]
Gower-Rousseau, C. [1 ]
Colombel, J. F. [4 ]
Poulain, D. [1 ,2 ]
机构：
[1] Univ Lille, INSERM, CHU Lille, LIRIC,UMR995, Lille, France
[2] CHU Lille, Parasitol Mycol, Inst Microbiol Lille, Lille, France
[3] CHU Lille, Inst Biochim & Biol Mol, Lab Biochim, Lille, France
[4] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA
来源：
VIRULENCE | 2018年 / 9卷 / 01期
关键词：
Anti-Saccharomyces cerevisiae antibodies (ASCA); Crohn's disease; Inflammatory Bowel Diseases; pathogenesis; uric acid; yeasts; INFLAMMATORY-BOWEL-DISEASE; CANDIDA-ALBICANS; GLYCAN ANTIBODIES; MARKERS; MANNAN; TRANSMISSION; PREVALENCE; VIRULENCE; STRAINS; FUNGI;
D O I：
10.1080/21505594.2018.1496779
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
下载
收藏
页码：1224 / 1229
页数：6
相关论文
共 50 条
  • [1] Confirmation of the importance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease.
    Peeters, M
    Vermeire, S
    Dantonio, R
    Baert, F
    D'Haens, G
    Vlietinck, R
    Sendid, B
    Colombel, JF
    Rutgeerts, P
    GASTROENTEROLOGY, 1998, 114 (04) : A1059 - A1059
  • [2] The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn's disease
    Eser, A.
    Papay, P.
    Primas, C.
    Pernicka, E.
    Harrer, M.
    Dejaco, C.
    Novacek, G.
    Lichtenberger, C.
    Angelberger, S.
    Kazemi, L.
    Mikulits, A.
    Vogelsang, H.
    Reinisch, W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (02) : 292 - 299
  • [3] The value of anti-Saccharomyces cerevisiae antibodies (ASCA) as subclinical marker in Crohn's disease (CD).
    Vermeire, S
    Peeters, M
    Joossens, S
    Dantonio, R
    Bossuyt, L
    Sendid, B
    Poulain, D
    Colombel, JF
    Rutgeerts, P
    GASTROENTEROLOGY, 1999, 116 (04) : A839 - A839
  • [4] Optimising the diagnostic value of Anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn’s disease
    Frank H. Klebl
    Frauke Bataille
    Ferdinand Hofstädter
    Hans Herfarth
    Jürgen Schölmerich
    Gerhard Rogler
    International Journal of Colorectal Disease, 2004, 19 : 319 - 324
  • [5] Optimising the diagnostic value of Anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease
    Klebl, FH
    Bataille, F
    Hofstädter, F
    Herfarth, H
    Schölmerich, J
    Rogler, G
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2004, 19 (04) : 319 - 324
  • [6] Anti-pancreatic (PAB) and anti-saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease in Quebec
    Vermeire, S
    Norman, G
    Dufresne, L
    Cousineau, J
    Ghandi, Z
    Pellerin, N
    Bernier, ML
    Bitton, A
    Wild, G
    GASTROENTEROLOGY, 2002, 122 (04) : A176 - A176
  • [7] Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet's syndrome
    Fresko, I
    Ugurlu, S
    Ozbakir, F
    Celik, A
    Yurdakul, S
    Hamuryudan, V
    Yazici, H
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (04) : S67 - S70
  • [8] Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease
    Granito, A
    Muratori, L
    Muratori, P
    Guidi, M
    Lenzi, M
    Bianchi, FB
    Volta, U
    GUT, 2006, 55 (02) : 296 - 296
  • [9] Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) decrease after surgery in patients with Crohn's disease
    Cassagnou, M
    Vermeire, S
    Sendid, B
    Charrier, G
    Rurgeerts, P
    Poulain, D
    Colombel, JF
    GASTROENTEROLOGY, 1999, 116 (04) : A687 - A687
  • [10] Association between anti-Saccharomyces Cerevisiae antibodies (ASCA) and clinical patterns of Crohn's disease (CD).
    Sambuelli, AM
    Negreira, S
    Villalva, S
    Gil, A
    Huernos, S
    Bai, J
    GASTROENTEROLOGY, 2002, 122 (04) : A178 - A179
12345